Marine mammals, like seals, dolphins, and whales, are vital components of the ocean’s ecosystem. However, these charismatic creatures face increasing threats from pollution, which can expose them to harmful pathogens. One such pathogen, Aeromonas veronii, is a bacterium commonly found in aquatic environments that poses a growing concern to marine mammals who a commonly exposed to contaminated water. With the rising occurrence of waterborne diseases, the need for rapid pathogen identification has never been more critical. Enter Next-Generation Sequencing (NGS)—a groundbreaking technology that can transform how we detect and treat infections in marine mammals!

Understanding Aeromonas veronii and Its Role in Aquatic Pathology

Aeromonas veronii is a gram-negative bacterium belonging to the Aeromonas genus, which includes bacteria often found in freshwater and marine environments, while it can also thrive in water contaminated by pollutants such as industrial waste, sewage, and agricultural runoff. As an opportunistic pathogen, A. veronii infects a wide range of hosts, including fish, amphibians, and marine mammals.

When marine mammals are exposed to contaminated water, either through direct contact with pollutants or through the ingestion of contaminated prey, they become susceptible to infections caused by opportunistic pathogens like A. veronii. A. veronii has been linked to a variety of diseases in aquatic animals, including gastroenteritis, septicemia, and wound infections. In marine mammals, such infections can cause significant morbidity and even mortality, especially when combined with other stressors such as habitat degradation, climate change, or compromised immune systems.

Contaminated Water Impacts the Health of Marine Mammals

The contamination of marine ecosystems is a growing global concern, with human activity being one of the primary contributors to water pollution. Agricultural runoff, industrial discharge, and untreated sewage introduce a wide range of contaminants, including bacteria, heavy metals, and chemical pollutants, into the oceans. As top predators in their ecosystems, marine mammals are particularly vulnerable to these environmental changes. This is because they often live in coastal regions, where pollution levels are highest, and rely on clean water sources for survival.

When marine mammals are exposed to contaminated water, they are at risk of developing infections caused by both bacterial and viral pathogens. Among these, Aeromonas veronii has gained attention due to its widespread presence in aquatic environments and its potential to cause disease in marine species. The bacterium is capable of surviving in harsh environmental conditions, including fluctuating temperatures, salinity, and nutrient levels, making it a persistent threat in polluted waters.

Infected marine mammals can experience a range of symptoms, from localized skin lesions and respiratory distress to systemic infections that affect vital organs. For example, A. veronii has been implicated in cases of necrotizing fasciitis and septicemia in fish, and similar conditions could occur in marine mammals exposed to the pathogen. The clinical presentation of A. veronii infections in marine mammals is often nonspecific, making it difficult to diagnose without advanced detection methods.

The Need for Rapid Detection of A. veronii. For Better Treatment

As the threat of waterborne pathogens like Aeromonas veronii grows, the need for rapid and accurate diagnosis has become more urgent. Traditional methods of pathogen detection, such as culturing and PCR testing, are time-consuming and labor-intensive. These methods often take days or even weeks to provide results, which can delay treatment and exacerbate the spread of infection.

Traditional diagnostics can be particularly detrimental when dealing with marine mammals, as infections can progress rapidly in these animals. Early detection and timely intervention are essential to prevent the spread of infections within populations and to ensure that individuals receive appropriate treatment before their condition worsens. This is where Next-Generation Sequencing (NGS) comes into play!

The Power of Next-Generation Sequencing (NGS)

Next-Generation Sequencing (NGS) represents a revolution in pathogen detection, offering an unprecedented ability to identify and characterize microorganisms with speed and accuracy. Unlike traditional methods, NGS allows for the sequencing of entire genomes, providing a comprehensive view of the microbial community in a given sample. This includes both known and novel pathogens, making it an invaluable tool for identifying infections that may otherwise go undetected.

In the case of Aeromonas veronii infections in marine mammals, NGS can significantly enhance our ability to detect and diagnose the pathogen. By analyzing samples from marine mammals – such as blood, tissues, or respiratory secretions—NGS can quickly identify the presence of A. veronii and other potential pathogens. The ability to detect multiple pathogens simultaneously through metagenomic sequencing also allows for a more holistic approach to diagnosis, accounting for the possibility of co-infections that may complicate clinical outcomes.

One of the key benefits of NGS is its speed. While traditional methods can take several days to yield results, NGS can provide pathogen identification within hours to a few days, allowing for faster treatment decisions. Early detection of A. veronii can help veterinarians and marine mammal researchers initiate appropriate treatment regimens more quickly, potentially saving lives and reducing the spread of infection in affected populations.

Moreover, NGS provides a level of precision and sensitivity that traditional methods cannot match. With NGS, it is possible to detect low levels of bacterial DNA, even in complex environmental samples, which is crucial when dealing with pathogens that may not be present in large quantities. This sensitivity is particularly important in marine mammal populations, where an animal’s condition may deteriorate quickly and subtle signs of infection may go unnoticed.

Benefits of NGS for Public Health and Conservation Efforts

The integration of NGS into marine mammal health management has significant benefits for both public health and conservation efforts. For one, it enhances our ability to monitor the health of marine mammal populations and track the spread of infectious diseases. By identifying pathogens like Aeromonas veronii early, researchers can develop targeted interventions and prevention strategies to protect vulnerable species from outbreaks.

Furthermore, NGS can be used in conjunction with environmental monitoring programs to assess the quality of water sources in marine habitats. By identifying the presence of pathogens in water samples, scientists can pinpoint areas of concern and implement measures to reduce contamination, thereby safeguarding the health of marine mammals and other aquatic organisms.

The rapid identification of pathogens like A. veronii also supports efforts to mitigate the effects of pollution on marine ecosystems. By providing real-time data on the presence of harmful bacteria, NGS can help inform policy decisions related to water quality, pollution control, and wildlife conservation. Ultimately, NGS enables a more proactive and effective approach to managing the health of marine mammals and ensuring the sustainability of marine ecosystems.

Conclusion

Aeromonas veronii represents a significant threat to marine mammals exposed to contaminated water, with the potential to cause severe infections and disrupt marine ecosystems. The traditional methods of pathogen detection have limitations that can delay diagnosis and treatment, exacerbating the risks to vulnerable marine species. However, Next-Generation Sequencing (NGS) offers a powerful solution, providing rapid, accurate, and comprehensive pathogen identification. By leveraging NGS, researchers and veterinarians can more effectively combat infections, protect marine mammal populations, and contribute to the broader effort to conserve marine biodiversity in an era of increasing environmental stress.

References:

  1. Liu, Z. G., Zheng, A. F., Chen, M. M., Lian, Y. X., Zhang, X. K., Zhang, S. Z., … & Li, J. K. (2018). Isolation and identification of pathogenic Aeromonas veronii from a dead Yangtze finless porpoise. Diseases of Aquatic Organisms, 132(1), 13-22.
  2. Pereira, C. S., Amorim, S. D., Santos, A. F. D. M., Siciliano, S., Moreno, I. B., Ott, P. H., & Rodrigues, D. D. P. (2008). Plesiomonas Shigelloides and Aeromonadaceaefamily pathogens isolated from marine mammals of Southeastern Brazilian Coast.
  3. Sudheesh, P. S., Al-Ghabshi, A., Al-Mazrooei, N., & Al-Habsi, S. (2012). Comparative pathogenomics of bacteria causing infectious diseases in fish. International journal of evolutionary biology, 2012(1), 457264.
  4. Li, T., Raza, S. H. A., Yang, B., Sun, Y., Wang, G., Sun, W., … & Shan, X. (2020). Aeromonas veronii infection in commercial freshwater fish: a potential threat to public health. Animals, 10(4), 608.

Wang, Y., Gao, C., Niu, W., Han, S., Qin, M., Tian, Z., … & Li, Y. (2024). Polystyrene microplastics promote intestinal colonization of Aeromonas veronii through inducing intestinal microbiota dysbiosis. Journal of Hazardous Materials,


Categories: Bacterial Infections, Marine Mammal, Next-Gen DNA Sequencing Technology

animal diagnostics

Validated by Veterinarians

“Clients expect their veterinarians to stay up to date on all matters that affect the health and well being of their non-human family members. The current technique that we have used to determine the presence and antibiotic sensitivity of organisms causing disease in our pets is over a century old.

With the emergence of dangerous antibacterial resistance, it is critical that veterinarians are able to offer laser focused diagnostics and treatment. MiDog enables us to offer care that exceeds the typical standard of care.”

Bernadine Cruz, DVM, Laguna Hills Animal Hospital Laguna Woods, CA

“I love the absolute abundance and comparing the fungal with bacterial infection. I do not worry as much about getting a false negative urinary infection reading as I do with traditional urine cultures. Several times the same urine would culture negative but MiDOG would detect pathogens.”

Michael Morgan, DVMQuail Animal Hospital, Tustin, CA

“The MiDOG All-in-One Test is amazing, I would use it instead of culture and sensitivity.  Such rapid and detailed results, I will reach for MiDOG before culture next time!

Thank you very much MiDOG, for sharing the opportunity to try your technology.”

Martha Smith-Blackmore, DVM, President of Forensic Veterinary Investigations, LLC – Boston, MA

The MiDOG All-in-One Microbial Test is our new gold standard of pathogen identification. The results are so accurate and valuable – especially with assessing both bacterial and fungal infections with the same sample.

Thank you MiDOG!”

Kathy Wentworth, DVM, Diplomate ABVP Canine and Feline Practice – PetPoint Medical Center, Irvine, CA

“The MiDOG staff was extremely helpful and supportive.”

Cathy Curtis, DVM – London, UK

“I have had great results using the MiDOG® Test. Compared to traditional culture tests, I am better able to target the treatment for dogs because the MiDOG® Test is so sensitive that it identifies all pathogens including bacteria and fungi, as well as antibiotic sensitivity.

The cost and turnaround time are about the same as a culture test, but I get much more data. The test has great performance and I believe the NGS technology will be a game changer for veterinarians treating dogs with lesions or other infections.”

Michael Kavanagh, DVM, Practice owner – Saddleback Animal Hospital, Tustin, CA

“It’s helpful to have an NGS spectrum because it gives you a broader insight of what’s happening and what might be going on.”

Richard Harvey BVSc DVD DipECVD PhD FRSB FRCVS – European Specialist in Veterinary Dermatology – Head of Dermatology, Willows Veterinary Centre & Referral Service – Solihull, England UK

“I have been using MiDog for over 4 years now and exclusively as my test of choice for all cultures for 3 years.  It is so great to submit a culture and feel confident there will be a result when it comes back, especially for urine cultures.  The reports were intimidating at first because they contain so much information.  After the first few, I am now quickly able to glance over it and pick out the highlights.  I can then come back later and pour over all the details.  I have been extremely pleased with my patients’ results using the test as well.  I don’t envision ever going back to traditional culture and susceptibilities again.”

Brian M. Urmson, DVM, Columbiana Veterinary Associates

“As an exotic veterinarian, there are numerous tests we have to consider to check specific bacterial and fungal organisms based on the species. MiDOG eliminates the need for many of these separate samples and provides definitive results quickly to help us treat our patients more efficiently and effectively. The lab is wonderful to work with and has never rejected our samples- they even processed a lizard toe we amputated and determined the cause of skin infection.”

Dr. Melissa Giese, Chicago Exotics Animal Hospital

“MiDOG’s diagnostic approach offers the unique ability to identify pathogens that evade traditional culture and sensitivity testing. I have found that adding a molecular based testing approach in the form of Next Generation Sequencing (NGS) from MiDOG to my routine diagnostic cultures can be extremely helpful in the identification and diagnosis of uncommon pathogens in veterinary medicine.”

Dr. Wayne Rosenkrantz, Animal Dermatology Clinic – Tustin

“She [Dr. Krumbeck] really did a great job of making complicated concepts accessible and demonstrating the value of your services. I’m really looking forward to working with MiDOG on my research project!”

Dr. Yaicha Peters, Animal Dermatology Clinic – San Diego

“As a proud collaborator with MiDOG, I deeply appreciate their dedication to fostering partnerships between industry and veterinary experts. Their commitment to enhancing diagnostic quality for veterinarians is commendable. In my experience, their support has been invaluable, earning them a ‘Double A+, Triple Star’ rating. Their assistance has been faultless, contributing significantly to the success of my projects and studies. I eagerly anticipate our continued collaboration.”

Dr. Richard Harvey, BVSc DVD DipECVD PhD FRSB FRCVS; European Specialist in Veterinary Dermatology

“We’re seeing that, if we prescribe too many antibiotics or they’re taken too frequently, animals are developing inappropriate or pathogenic strains of bacteria. We’re also seeing that our antibiotics are just not working against them anymore… It’s a good example of why we need better diagnostic testing, like MiDOG, so that we’re selecting the correct antibiotic every time our patients have an infection.”

Dr. Alissa Rexo, DVM, CVA, DACVD, Mid-Atlantic Veterinary Dermatology

“The NGS technique as offered by MiDOG is wonderful because pathogens like Melissococcus plutonius, for example, are difficult to grow and keep alive in the laboratory. A standard laboratory cannot truly examine or even properly diagnose this pathogen in bee hives at this time. But with NGS, we can reliably diagnose it.”

Dr. Joerg Mayer, Entomologist and Microbiologist at the University of Georgia

“For me, as a clinician and as a researcher, I see the immense value in the product [the All-in-One Test]. I have had great success using MiDOG clinically, including identifying Mycoplasma in a 24 year old pigeon, a Nannizziopsis spp in a ball python from a large pet distributor, Mycoplasma and Fusobacterium necrophorum co-infection in a peacock, and to identify an abnormal gut GI in a technician’s dog that tested negative for everything else (but we were able to establish what was abnormal, and work toward fixing it).”

Dr. Jeremy Rayl – Veterinarian, Block House Creek Animal Hospital, Cedar Park, Texas

“With MiDog results I not only receive a list of organisms detected in the sample, but also cell counts which allow me to target the most abundant pathogens or the most pathogenic. The identification of antimicrobial resistance genes is also helpful in selecting an appropriate antibiotic. Another benefit is that sample handling is less prone to risk of overgrowth and is stable at room temperature. Easy and informative. A great tool in our diagnostic toolbox!!”

Lauren Palmer DVM, MPH, Marine mammal Care Center Los Angeles

“If every rescue and sanctuary could run a scan on new admissions, I think it would open everyone’s eyes. These birds have been through so much and damaged by human pathogens. Plus the MiDog test was much more affordable than a battery of PCRs, several c&s, repeated tests, etc. AND non-invasive. Thank you. I would advise every sanctuary and other parrot facility to run MiDOG screening. I know it might reveal more than we want to know.”

Patricia Latas, DVM, Wild Parrot Coalition